DE:1FU6 ETF Price & Analysis
1FU6 ETF Chart & Stats
€28.00
--
Market closed
€28.00
--
Day’s Range― - ―
52-Week Range€18.12 - €30.00
Previous Close€28.01
VolumeN/A
Average Volume (3M)178.00
AUM16.76M
NAV33.17
Expense Ratio0.60%
Holdings Count31
Beta0.56
Inception DateMay 27, 2020
Next Dividend Ex-DateN/A
Dividend Yield
(―)Shares OutstandingN/A
Standard DeviationN/A
10 Day Avg. Volume24
30 Day Avg. Volume178
AlphaN/A
ETF Overview
First Trust NYSE Arca Biotechnology UCITS ETF
The First Trust NYSE Arca Biotechnology UCITS ETF, trading under the ticker DE:1FU6, is a specialized investment vehicle designed for those seeking targeted exposure within the dynamic health care sector. This ETF zeroes in on the biotechnology niche, a frontier of medical innovation where groundbreaking developments shape the future of health care. By investing in this fund, investors gain access to a curated portfolio of companies at the forefront of biotech advancements, ranging from genetic sequencing to cutting-edge pharmaceuticals and beyond. This ETF is not only a gateway to potential high-growth opportunities but also a means to align one's investment strategy with the rapidly evolving landscape of biotechnology. Suitable for investors with a keen interest in health care innovations, the First Trust NYSE Arca Biotechnology UCITS ETF offers a strategic approach to capturing the potential upside of the biotech revolution while navigating the complexities of this specialized market.
First Trust NYSE Arca Biotechnology UCITS ETF (1FU6) Fund Flow Chart
First Trust NYSE Arca Biotechnology UCITS ETF (1FU6) 1 year Net Flows: -€736K
1FU6 ETF News
1FU6 ETF FAQ
What was DE:1FU6’s price range in the past 12 months?
DE:1FU6 lowest ETF price was €18.12 and its highest was €30.00 in the past 12 months.
What is the AUM of DE:1FU6?
As of Sep 04, 2026 The AUM of DE:1FU6 is 16.76M.
Is DE:1FU6 overvalued?
According to Wall Street analysts DE:1FU6’s price is currently Undervalued.
Does DE:1FU6 pay dividends?
DE:1FU6 does not currently pay dividends.
How many shares outstanding does DE:1FU6 have?
Currently, no data Available
Which hedge fund is a major shareholder of DE:1FU6?
Currently, no hedge funds are holding shares in DE:1FU6
1FU6 ETF Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.
Top 10 Holdings
Halozyme Therapeutics
4.43%
Regeneron Pharmaceuticals
3.82%
NeoGenomics Inc.
3.78%
Natera Inc.
3.73%
Corcept Therapeutics
3.73%
Amgen Inc
3.69%
BeOne Medicines
3.68%
Sarepta Therapeutics Inc.
3.64%
Argenx
3.61%
Gilead Sciences
3.57%
Total37.66%
See All Holdings









